Monoclonal Antibody Therapies and Neurologic DisordersArch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
What Went Wrong in the Natalizumab Trials?Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006